PRODUCT OVERVIEW & COMPOSITION
Brand / Manufacturer: Bioniche Pharma
Active Ingredient: Methenolone Acetate USP (25 mg per tablet)
Pharmacological Class: Synthetic Anabolic-Androgenic Steroid (Non-$17\alpha$-alkylated Dihydrotestosterone derivative)
Bioniche Pharma Methenolone Acetate is an orally active anabolic agent that differs structurally from many oral steroids because it lacks $17\alpha$-alkylation. It offers high anabolic selectivity with minimal androgenic potency and zero estrogenic activity, providing tissue-building support without hepatotoxic $17\alpha$-alkylation strain.
CLINICAL PHARMACOLOGY & DYNAMICS
As a derivative of testosterone, Bioniche Pharma Methenolone Acetate binds to intracellular androgen receptors to shift nitrogen balance toward active protein synthesis. By stimulating cellular growth and division in skeletal muscle and bone tissue, it aids in tissue preservation and repair during catabolic states.
INDICATIONS & CLINICAL USE
- Palliative management of advanced hormone-responsive breast carcinoma in postmenopausal females using Bioniche Pharma formulations.
- Therapeutic support during recuperation from severe trauma, major surgical procedures, or chronic debilitating conditions with Bioniche Pharma anabolic support.
- Adjunctive treatment for growth impairment disorders under specialized Bioniche Pharma medical supervision.
CONTRAINDICATIONS
- Confirmed or suspected breast carcinoma in male patients.
- Breast cancer in females complicated by severe hypercalcemia (elevated blood calcium levels).
- Known or suspected prostatic carcinoma in males.
- Severe hepatic impairment or advanced renal failure.
- Pregnancy and lactation due to potential adverse fetal outcomes.
DOSAGE & ADMINISTRATION
Dosing regimes for Bioniche Pharma Methenolone Acetate must be tailored individually and administered under direct medical oversight based on therapeutic objectives, diagnostic blood work, and patient tolerance.
ADVERSE REACTIONS & PRECAUTIONS
Although Bioniche Pharma Methenolone Acetate exhibits low androgenic activity, androgenic side effects may still occur in sensitive individuals:
- Dermatological: Increased sebum production (oily skin), acne vulgaris, and accelerated facial or body hair growth (hirsutism) associated with Bioniche Pharma administration.
- Endocrine & Systemic: Potential suppression of endogenous gonadotropin secretion at elevated dosages, requiring periodic hormonal monitoring during Bioniche Pharma therapy.
STORAGE & HANDLING
Store Bioniche Pharma products in a cool, dry place away from direct light, high temperatures, and humidity. Keep strictly out of reach and sight of children.